Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Up 57.7% in April

Aethlon Medical, Inc. (NASDAQ:AEMD) was the recipient of a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 29,800 shares, a growth of 57.7% from the March 31st total of 18,900 shares. Approximately 1.3% of the shares of the company are short sold. Based on an average daily trading volume, of 8,200 shares, the short-interest ratio is presently 3.6 days.

Analyst Ratings Changes

Several research firms have commented on AEMD. HC Wainwright dropped their price objective on shares of Aethlon Medical from $23.00 to $10.00 and set a “buy” rating on the stock in a report on Monday, March 4th. StockNews.com assumed coverage on Aethlon Medical in a research note on Sunday. They set a “sell” rating for the company.

Aethlon Medical Stock Down 9.5 %

Shares of AEMD stock opened at $1.36 on Monday. Aethlon Medical has a 12-month low of $1.33 and a 12-month high of $5.00. The business has a 50-day moving average price of $1.64 and a two-hundred day moving average price of $1.75. The firm has a market cap of $3.56 million, a P/E ratio of -0.27 and a beta of 1.88.

Aethlon Medical (NASDAQ:AEMD) last announced its quarterly earnings data on Wednesday, February 14th. The medical equipment provider reported ($1.37) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($1.23) by ($0.14). As a group, research analysts expect that Aethlon Medical will post -4.98 EPS for the current fiscal year.

About Aethlon Medical

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.